Compare NKTR & EYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKTR | EYE |
|---|---|---|
| Founded | 1990 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 1996 | 2017 |
| Metric | NKTR | EYE |
|---|---|---|
| Price | $71.90 | $19.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $146.67 | $31.22 |
| AVG Volume (30 Days) | 1.2M | ★ 2.3M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 202.78 |
| EPS | N/A | ★ 0.38 |
| Revenue | $307,711,000.00 | ★ $1,987,488,000.00 |
| Revenue This Year | N/A | $5.56 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | ★ N/A | $51.08 |
| Revenue Growth | ★ 86.00 | 9.00 |
| 52 Week Low | $21.02 | $14.75 |
| 52 Week High | $109.00 | $30.02 |
| Indicator | NKTR | EYE |
|---|---|---|
| Relative Strength Index (RSI) | 59.67 | 56.15 |
| Support Level | $64.30 | $14.84 |
| Resistance Level | $76.67 | $29.56 |
| Average True Range (ATR) | 4.21 | 0.82 |
| MACD | 1.55 | 0.28 |
| Stochastic Oscillator | 77.06 | 70.63 |
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
National Vision Holdings Inc. is an optical retailer in the United States. Its product portfolio includes eyeglasses, sunglasses, contact lenses, accessories, and other related products. The company operates through a single operating segment. The Owned and Host segment includes the company-owned brands America's Best and Eyeglass World. In America's Best stores, vision care services are provided by optometrists or by independent professional corporations. The Host segment consists of Military and Fred Meyer locations, where eye exams are provided by independent optometrists.